Kaleido Biosciences Inc - ESG Rating & Company Profile powered by AI
Other companies in the rating industry group for Kaleido Biosciences Inc are shown. The webpage of Kaleido Biosciences Inc was assembled by All Street Sevva using leading NLP. The ESG score includes 17 UN Sustainable Development Goals including: 'Gender Equality', 'Industry, Innovation & Infrastructure' and 'Peace, Justice & Strong Institutions'.
Kaleido Biosciences Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1967 | Hospira Inc | 0.3 | Low |
| 1967 | PRA Health Sciences Inc | 0.3 | Low |
| 1970 | Kaleido Biosciences Inc | 0.0 | Low |
| 1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
| 1970 | CTC Bio Inc | 0.0 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Kaleido Biosciences Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Kaleido Biosciences Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Kaleido Biosciences Inc report the average age of the workforce?
Sign up for free to unlockDoes Kaleido Biosciences Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Kaleido Biosciences Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Kaleido Biosciences Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Kaleido Biosciences Inc offer flexible work?
Sign up for free to unlockDoes Kaleido Biosciences Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Kaleido Biosciences Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Kaleido Biosciences Inc conduct supply chain audits?
Sign up for free to unlockDoes Kaleido Biosciences Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Kaleido Biosciences Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Kaleido Biosciences Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Kaleido Biosciences Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Kaleido Biosciences Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Kaleido Biosciences Inc disclose water use targets?
Sign up for free to unlockDoes Kaleido Biosciences Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Kaleido Biosciences Inc have a product recall in the last two years?
Sign up for free to unlockDoes Kaleido Biosciences Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Kaleido Biosciences Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Kaleido Biosciences Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Kaleido Biosciences Inc disclose parental leave metrics?
Sign up for free to unlockDoes Kaleido Biosciences Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Kaleido Biosciences Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Kaleido Biosciences Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Kaleido Biosciences Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Kaleido Biosciences Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Kaleido Biosciences Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Kaleido Biosciences Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Kaleido Biosciences Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Kaleido Biosciences Inc disclose its waste policy?
Sign up for free to unlockDoes Kaleido Biosciences Inc report according to TCFD requirements?
Sign up for free to unlockDoes Kaleido Biosciences Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Kaleido Biosciences Inc disclose energy use targets?
Sign up for free to unlockDoes Kaleido Biosciences Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Kaleido Biosciences Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Kaleido Biosciences Inc
These potential risks are based on the size, segment and geographies of the company.
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the treatment of multi drug resistant infection, chronic kidney disease, atherosclerotic cardiovascular disease, cardio-metabolic syndrome, immuno-oncology, and inflammatory bowel diseases. The company has collaboration agreements with Institute Gustave Roussy, Washington University, and Janssen. Kaleido Biosciences, Inc. was incorporated in 2015 and is headquartered in Lexington, Massachusetts.